Published: 2018-12-17

Acne & Rosacea

Atopic Dermatitis

GBR 830 Induced Progressive and Sustained Improvements in Atopic Dermatitis Skin Biomarkers and Clinical Parameters

Emma Guttman-yassky, Ana B Pavel, Yeriel Estrada, Lisa Zhou, Yacine Salhi, Girish Gudi, Vinu Ca, Julie Macoin, Jonathan Back, Gerhard Wolff

Page S61

Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses

Julie Macoin, Rami Lissilaa, Pavankumar Sancheti, Venkateshwar Reddy, Jonathan Back, Gerhard Wolff

Page S62

Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis

Andreas Wollenberg, Emma Guttman-Yassky, Mathias Torpet, Jonathan I Silverberg

Page S63



Non-Melanoma Skin Cancers and Benign Cutaneous Tumors

Open-Label Study of A-101, a 40% Hydrogen Peroxide Topical Solution, in Patients With Seborrheic Keratosis

Valerie Callender, Ellen Frankel, Jonathan Weiss, William Werschler, Christopher Powala, Brian Beger, Esther Estes, Stuart Shanler

Page S75

Poster Presentations from FC23 Dermatology Conference®: Psoriasis


Rising Derm Stars® Abstracts